Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis
10.1038/28867
Crossref journal-article
Springer Science and Business Media LLC
Nature (297)
Bibliography

Carmeliet, P., Dor, Y., Herbert, J.-M., Fukumura, D., Brusselmans, K., Dewerchin, M., Neeman, M., Bono, F., Abramovitch, R., Maxwell, P., Koch, C. J., Ratcliffe, P., Moons, L., Jain, R. K., Collen, D., & Keshet, E. (1998). Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis. Nature, 394(6692), 485–490.

Authors 16
  1. Peter Carmeliet (first)
  2. Yuval Dor (additional)
  3. Jean-Marc Herbert (additional)
  4. Dai Fukumura (additional)
  5. Koen Brusselmans (additional)
  6. Mieke Dewerchin (additional)
  7. Michal Neeman (additional)
  8. Françoise Bono (additional)
  9. Rinat Abramovitch (additional)
  10. Patrick Maxwell (additional)
  11. Cameron J. Koch (additional)
  12. Peter Ratcliffe (additional)
  13. Lieve Moons (additional)
  14. Rakesh K. Jain (additional)
  15. Désiré Collen (additional)
  16. Eli Keshet (additional)
References 30 Referenced 2,042
  1. Bunn, H. F. & Poyton, R. O. Oxygen sensing and molecular adaptation to hyopoxia. Physiol. Rev. 76, 839–885 (1996). (10.1152/physrev.1996.76.3.839) / Physiol. Rev. by HF Bunn (1996)
  2. Wenger, R. H. & Gassmann, M. Oxygen(s) and the hypoxia-inducible factor-1. Biol. Chem. 378, 609–616 (1997). / Biol. Chem. by RH Wenger (1997)
  3. Semenza, G. L. Transcriptional regulation by hypoxia-inducible factor-1. Trends Cardiovasc. Med. 6, 151–157 (1996). (10.1016/1050-1738(96)00039-4) / Trends Cardiovasc. Med. by GL Semenza (1996)
  4. Iyer, N. V.et al. Cellular and developmental control of O2 homeostasis by hypoxia-inducible factor-1α. Genes Dev. 12, 149–162 (1998). (10.1101/gad.12.2.149) / Genes Dev. by NV Iyer (1998)
  5. Dor, Y. & Keshet, E. Ischemia-driven angiogenesis. Trends Cardiovasc. Med. 7, 289–294 (1997). (10.1016/S1050-1738(97)00091-1) / Trends Cardiovasc. Med. by Y Dor (1997)
  6. Gartel, A. L., Serfas, M. S. & Tyner, A. L. p21–negative regulator of the cell cycle. Proc. Soc. Exp. Biol. Med. 213, 138–149 (1996). (10.3181/00379727-213-44046) / Proc. Soc. Exp. Biol. Med. by AL Gartel (1996)
  7. Toyoshima, H. & Hunter, T. p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21. Cell 78, 67–74 (1994). (10.1016/0092-8674(94)90573-8) / Cell by H Toyoshima (1994)
  8. Price, B. D. & Calderwood, S. K. Gadd45 and Gadd153 messenger RNA levels are increased during hypoxia and after exposure of cells to agents which elevate the levels of the glucose-regulated proteins. Cancer Res. 52, 3814–3817 (1992). / Cancer Res. by BD Price (1992)
  9. Little, E., Ramakrishnan, M., Roy, B., Gazit, G. & Lee, A. S. The glucose-regulated proteins (GRP78 and GRP94): functions, gene regulation, and applications. Crit. Rev. Eukaryot. Gene Expr. 4, 1–18 (1994). (10.1615/CritRevEukarGeneExpr.v4.i1.10) / Crit. Rev. Eukaryot. Gene Expr. by E Little (1994)
  10. Wood, S. M.et al. Selection and analysis of a mutant cell line defective in the hypoxia-inducible factor-1α subunit. Characterization of HIF-1α dependent and independent hypoxia-inducible gene expression. J. Biol. Chem. 273, 8360–8367 (1998). (10.1074/jbc.273.14.8360) / J. Biol. Chem. by SM Wood (1998)
  11. Liebermann, D. A., Hoffman, B. & Steinman, R. A. Molecular controls of growth arrest and apoptosis: p53-dependent and independent pathways. Oncogene 11, 199–210 (1995). / Oncogene by DA Liebermann (1995)
  12. Cox, L. S. Multiple pathways control cell growth and transformation: overlapping and independent activities of p53 and p21Cip1/WAF1/Sdi1. J. Pathol. 183, 134–140 (1997). (10.1002/(SICI)1096-9896(199710)183:2<134::AID-PATH960>3.0.CO;2-D) / J. Pathol. by LS Cox (1997)
  13. Graeber, T. G.et al. Hypoxia induces accumulation of p53 protein, but activation of a G1-phase checkpoint by low-oxygen conditions is independent of p53 status. Mol. Cell. Biol. 14, 6264–6277 (1994). (10.1128/MCB.14.9.6264) / Mol. Cell. Biol. by TG Graeber (1994)
  14. Strasser, A., Huang, D. C. & Vaux, D. L. The role of the bcl-2/ced-9 gene family in cancer and general implications of defects in cell death control for tumorigenesis and resistance to chemotherapy. Biochim. Biophys. Acta 1333, F151–178 (1997). / Biochim. Biophys. Acta by A Strasser (1997)
  15. Maxwell, P. H.et al. Hypoxia-inducible factor-1 modulates gene expression in solid tumors and influences both angiogenesis and tumor growth. Proc. Natl Acad. Sci. USA 94, 8104–8109 (1997). (10.1073/pnas.94.15.8104) / Proc. Natl Acad. Sci. USA by PH Maxwell (1997)
  16. Maltepe, E., Schmidt, J. V., Baunoch, D., Bradfield, C. A. & Simon, C. M. Abnormal angiogenesis and responses to glucose and oxygen deprivation in mice lacking the protein ARNT. Nature 386, 403–407 (1997). (10.1038/386403a0) / Nature by E Maltepe (1997)
  17. Schmaltz, C., Harrigan Hardenbergh, P., Wells, A. & Fisher, D. E. Regulation of proliferation–survival decisions during tumor cell hypoxia. Mol. Cell. Biol. 18, 2845–2854 (1998). (10.1128/MCB.18.5.2845) / Mol. Cell. Biol. by C Schmaltz (1998)
  18. Collins, M. K., Perkins, G. R., Rodriguez Tarduchy, G., Nieto, M. A. & Lopez Rivas, A. Growth factors as survival factors: regulation of apoptosis. Bioessays 16, 133–138 (1994). (10.1002/bies.950160210) / Bioessays by MK Collins (1994)
  19. Lin, Y. & Benchimol, S. Cytokines inhibit p53-mediated apoptosis but not p53-mediated G1 arrest. Mol. Cell. Biol. 15, 6045–6054 (1995). (10.1128/MCB.15.11.6045) / Mol. Cell. Biol. by Y Lin (1995)
  20. Vaupel, P. The influence of tumor blood flow and microenvironmental factors on the efficacy of radiation, drugs and localized hyperthermia. Klin. Pädiatr. 209, 243–249 (1997). (10.1055/s-2008-1043957) / Klin. Pädiatr. by P Vaupel (1997)
  21. Yuan, F.et al. Time-dependent vascular regression and permeability changes in established human tumor xenografts induced by an anti-vascular endothelial growth factor/vascular permeability factor antibody. Proc. Natl Acad. Sci. USA 93, 14765–14770 (1996). (10.1073/pnas.93.25.14765) / Proc. Natl Acad. Sci. USA by F Yuan (1996)
  22. Graeber, T. G.et al. Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours. Nature 379, 88–91 (1996). (10.1038/379088a0) / Nature by TG Graeber (1996)
  23. Helmlinger, G., Yuan, F., Dellian, M. & Jain, R. K. Interstitial pH and p O2 gradients in solid tumors in vivo: high-resolution measurements reveal a lack of correlation. Nature Med. 3, 177–182 (1997). (10.1038/nm0297-177) / Nature Med. by G Helmlinger (1997)
  24. An, W. G.et al. Stabilization of wild-type p53 by hypoxia-inducible factor-1α. Nature 392, 405–408 (1998). (10.1038/32925) / Nature by WG An (1998)
  25. Jiang, B. H., Rue, E., Wang, G. L., Roe, R. & Semenza, G. L. Dimerization, DNA binding, and transactivation properties of hypoxia-inducible factor-1. J. Biol. Chem. 271, 17771–17778 (1996). (10.1074/jbc.271.30.17771) / J. Biol. Chem. by BH Jiang (1996)
  26. Carmeliet, P.et al. Abnormal blood vessel development and lethality in embryos lacking a single vascular endothelial growth-factor allele. Nature 380, 435–439 (1996). (10.1038/380435a0) / Nature by P Carmeliet (1996)
  27. Abramovitch, R., Frenkiel, D. & Neeman, M. Analysis of subcutaneous angiogenesis by gradient echo magnetic resonance imaging. Magn. Reson. Med. 39, 813–824 (1998). (10.1002/mrm.1910390519) / Magn. Reson. Med. by R Abramovitch (1998)
  28. Kobayashi, N., Kobayashi, K., Kouno, K., Horinaka, S. & Yagi, S. Effects of intra-arterial injection of colored microspheres on systemic hemodynamics and regional blood flow in rats. Am. J. Physiol. 266, H1910–H1917 (1994). / Am. J. Physiol. by N Kobayashi (1994)
  29. Evans, S. M.et al. Identification of hypoxia in cells and tissues of epigastric 9L rat glioma using EF5 (2-(2-nitro-1H-imidazol-1-yl)- N -(2,2,3,3,3-pentafluoropropyl) acetamide). Br. J. Cancer 72, 875–882 (1995). (10.1038/bjc.1995.427) / Br. J. Cancer by SM Evans (1995)
  30. Herbert, J. M. & Carmeliet, P. Involvement of u-PA in the anti-apoptotic activity of TGFβ for vascular smooth muscle cells. FEBS Lett. 413, 401–404 (1997). (10.1016/S0014-5793(97)00915-0) / FEBS Lett. by JM Herbert (1997)
Dates
Type When
Created 23 years ago (July 26, 2002, 4:39 a.m.)
Deposited 2 years, 3 months ago (May 16, 2023, 8:10 p.m.)
Indexed 3 days ago (Aug. 20, 2025, 9:18 a.m.)
Issued 27 years ago (July 30, 1998)
Published 27 years ago (July 30, 1998)
Published Print 27 years ago (July 30, 1998)
Funders 0

None

@article{Carmeliet_1998, title={Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis}, volume={394}, ISSN={1476-4687}, url={http://dx.doi.org/10.1038/28867}, DOI={10.1038/28867}, number={6692}, journal={Nature}, publisher={Springer Science and Business Media LLC}, author={Carmeliet, Peter and Dor, Yuval and Herbert, Jean-Marc and Fukumura, Dai and Brusselmans, Koen and Dewerchin, Mieke and Neeman, Michal and Bono, Françoise and Abramovitch, Rinat and Maxwell, Patrick and Koch, Cameron J. and Ratcliffe, Peter and Moons, Lieve and Jain, Rakesh K. and Collen, Désiré and Keshet, Eli}, year={1998}, month=jul, pages={485–490} }